Anzemet and Incisional drainage - a phase IV clinical study of FDA data

Summary:

Incisional drainage is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are male, 50-59 old, also take Taxotere, and have Arthritis.

The phase IV clinical study analyzes which people have Incisional drainage when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Incisional drainage?

Incisional drainage is found to be associated with 198 drugs and 269 conditions by eHealthMe. Check the latest studies of Incisional drainage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 25 people (0.97%) have Incisional drainage.

Could Anzemet cause Incisional drainage?

Among these 25 people:

What is the gender of people who have Incisional drainage when taking Anzemet? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Incisional drainage when taking Anzemet? *

What are other drugs people take besides Anzemet? *

What are other side effects people have besides Incisional drainage? *

Swelling: 25 people, 100.00%
Bone Disorder: 25 people, 100.00%
Pleural Effusion (water on the lungs): 25 people, 100.00%
Blood Creatinine Increased: 25 people, 100.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 25 people, 100.00%
Impaired Healing: 25 people, 100.00%
Osteomyelitis (infection of bone): 25 people, 100.00%
Dyspnea (difficult or laboured breathing): 25 people, 100.00%
Pain In Extremity: 25 people, 100.00%
Toothaches (tooth pain): 20 people, 80.00%

What are the existing conditions these people have? *

Sleep Disorder: 17 people, 68.00%
Nausea (feeling of having an urge to vomit): 17 people, 68.00%
Muscle Spasms (muscle contraction): 17 people, 68.00%
Depression: 17 people, 68.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 68.00%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 13 people, 52.00%
Pain: 8 people, 32.00%
Metastases To Bone (cancer spreads to bone): 8 people, 32.00%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Incisional drainage?

- Check whether Incisional drainage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Anzemet (2,603 reports)

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Incisional drainage:

Incisional drainage (198 drugs)

Browse all the conditions that are associated with Incisional drainage:

Incisional drainage (269 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.